APAC MedTech Expansion Leadership Risks

Why APAC MedTech Companies Struggle to Build US and European Leadership Teams

APAC MedTech companies are increasingly entering the US and European markets with innovative products, strong clinical data, and ambitious growth plans – but the leadership problem no one wants to admit is that most expansion strategies stall long before the product becomes the issue.

The product is rarely the problem. The org chart is.

Across the industry, there is a recurring pattern. Businesses focus heavily on regulatory pathways, distribution partnerships, reimbursement strategy, and product localisation, but underestimate the importance of building leadership infrastructure early enough to support expansion.

Critical Leaders Are Being Hired Too Late

One of the biggest issues facing APAC MedTech companies is delayed hiring.

Regulatory Affairs, Clinical Affairs, Market Access, and Commercial leaders are often only recruited once execution has already started. By the time the organisation begins searching for experienced FDA or EU MDR talent, strategic timelines are already slipping.

This challenge is becoming increasingly significant as global regulatory frameworks become more complex. The US Food and Drug Administration continues to expand oversight and compliance requirements across medical devices. At the same time, the EU Medical Device Regulation (EU MDR) has dramatically increased the clinical and regulatory burden for companies entering Europe.

Without experienced leadership involved early, organisations often spend valuable time correcting avoidable mistakes later in the process.

The US MedTech Talent Market Is Highly Competitive

Senior MedTech talent in the US remains heavily supply-constrained.

Experienced leaders in Regulatory Affairs, Clinical Development, Quality, and Commercial Operations are continuously targeted by multinational MedTech businesses and well-funded venture-backed startups. In major hubs such as Boston, San Diego, and San Francisco, competition for proven FDA-facing talent is intense.

For APAC companies with limited employer branding in the West, attracting senior candidates becomes even more difficult. Candidates often perceive greater career risk when joining organisations without an established US or European presence.

The result is often prolonged hiring timelines, failed searches, or underqualified appointments that create operational problems further down the line.

Compensation Shock Creates Expansion Friction

Compensation benchmarking is another common issue.

Many APAC headquarters initially approve hiring budgets based on salary expectations in domestic markets such as Seoul, Shanghai, Singapore, or Tokyo. However, compensation expectations in US and European MedTech hubs are significantly higher.

When businesses underestimate market rates, they typically face two outcomes:

• Losing high-quality candidates during the process – often to competitors who moved faster and benchmarked more accurately against local market rates.
• Hiring below the level required for successful market entry – which typically creates operational and credibility problems that become significantly more expensive to resolve within 12 to 24 months.

Both scenarios usually become far more expensive operationally within 12–24 months.

The Country GM Role Is Under Pressure

The Country or Regional GM role is one of the most challenging positions in international MedTech expansion.

These leaders often sit between an APAC headquarters focused on speed and centralised decision-making, and Western healthcare markets that operate through relationship-building, trust, and long commercial sales cycles.

Without clear autonomy and alignment between regional and global leadership, turnover becomes common. When this role fails, distributor relationships weaken, commercial execution slows, and expansion momentum suffers.

The Unicorn Candidate Problem

Another recurring challenge is the search for the “perfect” hire.

Many companies attempt to recruit a single executive with:

• deep FDA expertise
• APAC cultural fluency
• Western commercial leadership experience
• reimbursement and payer knowledge
• startup adaptability
• below-market compensation expectations

In reality, this candidate rarely exists.

The organisations that scale most successfully understand that leadership capability needs to be built strategically across multiple hires rather than compressed into one unrealistic role profile.

Why Specialist MedTech Recruitment Partners Matter

This is where specialist MedTech recruitment firms like Skills Alliance can add significant value.

A specialist partner understands both the technical demands of the MedTech industry and the complexities of international expansion. Rather than simply filling vacancies, experienced recruiters can help businesses design realistic leadership structures, benchmark compensation accurately against local markets, and identify which hires need to be prioritised first.

They also provide access to passive senior talent that is rarely available through traditional hiring channels – particularly in Regulatory Affairs, Clinical Affairs, Quality, and Commercial leadership.

For APAC companies entering unfamiliar US or European markets, specialist recruiters can also help bridge cultural expectations between headquarters and regional leadership teams, reducing the risk of costly hiring mistakes and turnover.

The Companies That Succeed Treat Talent as Strategy

The APAC MedTech companies that scale successfully into the US and Europe tend to approach talent differently. Across the expansion strategies that work, a consistent pattern emerges – and it has very little to do with the product:

• They hire key leaders 12–18 months earlier.
• They benchmark compensation realistically.
• They empower regional leaders with genuine decision-making authority.
• And they treat talent acquisition as part of the market-entry strategy itself.

The product is rarely the problem. The org chart is.

For APAC MedTech companies navigating international expansion, partnering with a specialist MedTech recruitment company can help build the leadership infrastructure required for long-term commercial success.

By Tom Ringer, Consultant, Skills Alliance